No headlines found.
LifeMD to Report Second Quarter 2026 Financial Results on August 5
Globe Newswire (Fri, 24-Jul 4:05 PM ET)
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Globe Newswire (Tue, 23-Jun 8:00 AM ET)
Globe Newswire (Mon, 22-Jun 8:00 AM ET)
LifeMD Appoints Umesh Sripad as Chief Technology Officer
Globe Newswire (Mon, 1-Jun 8:05 AM ET)
LifeMD to Participate in Upcoming Investor Conferences
Globe Newswire (Fri, 15-May 8:00 AM ET)
LifeMD Reports First Quarter 2026 Results
Globe Newswire (Wed, 6-May 4:05 PM ET)
LifeMD, Inc. - 8.875% Series A Cumulative Perpetual Preferred Stock trades on the stock market under the symbol LFMDP.
As of July 29, 2026, LFMDP stock price climbed to $23.50 with 1,646 million shares trading.
LFMDP has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, LFMDP traded as high as $27.44 and as low as $17.15.
LFMDP has underperformed the market in the last year with a return of +6.1%, while the SPY ETF gained +16.0%. In the last 3 month period, LFMDP fell short of the market, returning +1.7%, while SPY returned +2.8%. However, in the most recent 2 weeks LFMDP has outperformed the stock market by returning +0.4%, while SPY returned -3.4%.
LFMDP support price is $23.20 and resistance is $23.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMDP shares will trade within this expected range on the day.
